NOP2 (also named NSUN1, p120) has been improved primarily for its protumorigenic roles in many cancers such as prostate cancer, gallbladder cancer, lung adenocarcinoma, and several other cancers, consistent with our study [34, 49, 50]. The gene discussed is NOP2; the disease is lung adenocarcinoma.